Suchergebnisse - "Isakova-Sivak, Irina"

PubPharm (7)

1

The future of haemagglutinin stalk-based universal influenza vaccines

enthalten in: The Lancet. Infectious diseases | 2022

von Isakova-Sivak, I. | Rudenko, L.

CommentOn: Lancet Infect Dis. 2022 Jul;22(7):1062-1075. - PMID 35461522

2

Influenza vaccine : progress in a vaccine that elicits a broad immune response

enthalten in: Expert review of vaccines | 2021

von Isakova-Sivak, I. | Stepanova, E. | Mezhenskaya, D. | +5

3

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin

enthalten in: Virology | 2018

von Isakova-Sivak, I. | Korenkov, D. | Smolonogina, T. | +6

4

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

enthalten in: BioMed research international | 2017

von Rekstin, A. | Isakova-Sivak, I. | Petukhova, G. | +8

5

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses

enthalten in: Vaccine | 2015

von Kiseleva, I. | Dubrovina, I. | Fedorova, E. | +7

6

Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model

enthalten in: Clinical and vaccine immunology : CVI | 2014

von Isakova-Sivak, I. | Chen, L. | Bourgeois, M. | +8

7

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus

enthalten in: Vaccine | 2013

von Rudenko, L. | Isakova-Sivak, I. | Donina, S.

1
[1]